CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Biodel

For profit

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

May 1, 2015

Acquired by Albireo → Ipsen on Nov 3, 2016

Timeline

2000s

Jan 1, 2003
Biodel— Founded

2010s

Nov 3, 2016
Albireo— Acquired By

2020s

Jan 9, 2023
Ipsen— Now

Drugs by trial phase (4 distinct, 17 trials)

Phase 3 (3 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

glucagon

Indications

Studied for

Recent trials (18)

NCT02446028Lead sponsorPhase 2May 1, 2015
NCT02403648Study directorPhase 1Nov 1, 2014
NCT02403648Lead sponsorPhase 1Nov 1, 2014
NCT02212951Lead sponsorPhase 1/Phase 2May 1, 2014
NCT02324309Lead sponsorPhase 1/Phase 2May 1, 2014
NCT01686620Lead sponsorPhase 2Aug 1, 2012
NCT01811849Lead sponsorPhase 1Aug 1, 2012
NCT01908894Lead sponsorPhase 1Feb 1, 2012
NCT01334151Lead sponsorPhase 1Mar 1, 2011
NCT01067118CollaboratorPhase 2Apr 1, 2010
NCT01110746Lead sponsorPhase 3Feb 1, 2010
NCT01235039Lead sponsorPhase 1/Phase 2Jul 1, 2009
NCT00849576Lead sponsorPhase 3Apr 1, 2008
NCT00875108Lead sponsorPhase 3Jul 1, 2007
NCT00875459Lead sponsorPhase 3Apr 1, 2007

Details

Founded: Danbury, CT, US Jan 1, 2003
Last known activity: May 1, 2015